EUVIMEDEUVIMED entdecken
Crossref

EE147 COST EFFECTIVENESS OF EARLY VS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA

Jacob Vang

Value in Health · 2026-06 · 29 (6) · S90-S91

DOI: 10.1016/j.jval.2026.03.442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Jacob Vang.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vang, J. (2026). EE147 COST EFFECTIVENESS OF EARLY VS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA. Value in Health, 29(6), S90-S91. https://doi.org/10.1016/j.jval.2026.03.442

Vancouver

Vang J. EE147 COST EFFECTIVENESS OF EARLY VS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA. Value in Health. 2026;29(6):S90-S91. doi:10.1016/j.jval.2026.03.442

BibTeX
@article{Vang2026,
  author = {Vang, Jacob},
  title = {EE147 COST EFFECTIVENESS OF EARLY VS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S90--S91},
  doi = {10.1016/j.jval.2026.03.442}
}
Kostenlos starten →